Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)

Baxter

Status: Completed

Conditions: Infection; Seroma; Necrosis

Study type: Observational

Funder types: Industry

Identifiers

NCT01454713

10-001

Details and patient eligibility

About

Retrospective data collection of the use of Veritas in breast reconstruction surgery

Full description

This is a multi-center study to retrospectively collect data on the use of Veritas Collagen Matrix in breast reconstruction. Data will be collected on post-operative complications in immediate breast reconstruction and then be compared to literature reported post-operative complication rates associated with the use of acellular dermal matrix in immediate breast reconstruction.

Enrollment: 54 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 years or older
• Patients who underwent mastectomy with immediate breast reconstruction using Veritas collagen matrix
• Patients who underwent mastectomy with single stage procedures or two-stage procedures using Veritas collagen matrix

Exclusion criteria

• Patients who underwent delayed breast reconstruction
• Reconstruction with something other than Veritas collagen matrix
• Breasts that were created with DIEP or TRAM procedures

Trial design

54 participants in 1 patient group

Veritas

Description:

Breast reconstruction with Veritas